Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
The Oncology Journal Club Episode 14: ESMO Special 2
Today’s episode of The Oncology Journal Club is the second of our ESMO Special Episodes…
Radiotherapy tattoos can be a painful reminder of cancer – but 3D imaging could be the solution
Heidi Probst, Sheffield Hallam University Every day in the UK over 150 women will be…
A promising new tool in the fight against melanoma
An Edith Cowan University (ECU) study has revealed that a key blood marker of cancer…
Cancer survivors find online and phone communication with medical professionals beneficial
Advances in cancer care have led to a rise in the number of people surviving the illness. Cancer survival rates…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.